Stay updated on Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.

Latest updates to the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page
- Check2 days agoChange DetectedMinor system revision update: v3.3.4 was added and v3.3.3 was removed from the page.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedLocations section added listing Michigan, New York, Oregon, and Washington; Revision: v3.3.3.SummaryDifference0.5%

- Check45 days agoChange DetectedThe page footer now shows Revision: v3.3.2 replacing v3.3.1, with no impact on study details or functionality; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check52 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1 on this page; this change appears to be a minor metadata update with no impact on content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check60 days agoChange DetectedThe government funding lapse notice was removed from the page; study details, locations, and eligibility criteria remain unchanged.SummaryDifference0.4%

- Check74 days agoChange DetectedThe page content appears unchanged between the two screenshots, with no new or removed information detected.SummaryDifference0.4%

Stay in the know with updates to Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.